anitch® 快訊
Anesinin®: The Breakthrough Changing Eczema Care
於 2025 年 9月 25 日
For decades, eczema has been managed with the same tools: steroids to suppress inflammation, and antibiotics to kill bacteria. While these approaches can bring short-term relief, they often leave patients stuck in a cycle of flare-ups, side effects, and microbiome imbalance.
How Staph Triggers Eczema — and How Anitch® Brings Relief with Anesinin®
於 2025 年 9月 23 日
Eczema, or atopic dermatitis, is more than just dry, itchy skin. At its root, scientists have found that Staphylococcus aureus (Staph) bacteria are a major driver of flare-ups. Unlike traditional treatments that suppress the immune system or kill bacteria indiscriminately, new science shows that targeting toxins — not bacteria — is the key to breaking the eczema cycle.
The Skin Microbiome & Eczema: How Tiny Organisms Shape Our Skin Health
於 2025 年 9月 22 日
Eczema flare-ups? Science points to one culprit: Staphylococcus aureus. But new research shows friendly bacteria may hold the key to restoring balance. Explore the future of eczema care in our latest blog.
